Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or BothMarc A. Pfeffer, Robert M. Califf, John J.V. McMurray et al.|New England Journal of Medicine|2003Cited by 2.5k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A. Pfeffer, Jean‐Claude Tardif, Brian Claggett et al.|New England Journal of Medicine|2015Cited by 2.3k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 UpdateSidney C. Smith, Kathryn A. Taubert, Jerilyn K. Allen et al.|Circulation|2006Cited by 2.1k
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial InfarctionNagesh S. Anavekar, Marc A. Pfeffer, Robert M. Califf et al.|New England Journal of Medicine|2004Cited by 1.9k
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsMarcus Flather, Eugene Braunwald, Salim Yusuf et al.|The Lancet|2000Cited by 1.6k